Screening and Identification of Abnormal Expression Proteins and miRNA From Colonic Mucosa of Patients With Irritable Bowel Syndrome.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Irritable Bowel Syndrome
- Sponsor
- Chinese PLA General Hospital
- Enrollment
- 180
- Last Updated
- 15 years ago
Overview
Brief Summary
In the investigators study, the investigators will focus on the screening of the related proteins and miRNA to IBS in order to reveal the possible clues or molecular mechanism for this disorder.
Detailed Description
For the proteomic procedures, Our study groups extracted proteins from the cecum and sigmoid colon samples and ran on the two-dimensional gel electrophoresis (2-DE). The proteins on 2-DE were visualized by the silver stain, and then gel maps were scanned and analyzed with the Image Master 2D Elite. The obvious abnormal protein spots were identified by the mass spectrometry. Western blot 、 immunohistochemistry 、 mRNA and miRNA were also performed for further verification of the proteins.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with symptoms meeting Rome III criteria for diagnosis of IBS-C and IBS-D
Exclusion Criteria
- •Patients with organic illnesses or a history of major abdominal surgery
- •Major psychotic episode, mental retardation or dementia
- •Pregnant women and lactational women
- •Postinfectious IBS, PI-IBS
Outcomes
Primary Outcomes
Not specified